Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ventrus Announces Improved, FDA-Recommended Endpoints Proposed for Phase III Hemorrhoid Study
Ventrus Announces Improved, FDA-Recommended Endpoints Proposed for Phase III Hemorrhoid Study
Ventrus Announces Improved, FDA-Recommended Endpoints Proposed for Phase III Hemorrhoid Study
Submitted by
admin
on March 19, 2011 - 10:10am
Source:
Yahoo/GlobeNewsWire
News Tags:
Ventrus
hemorrhoids
iferanserin
Headline:
Ventrus Announces Improved, FDA-Recommended Endpoints Proposed for Phase III Hemorrhoid Study
Do Not Allow Advertisers to Use My Personal information
